ID   HD2BR
AC   CVCL_C3QI
SY   Huntington Disease 2 BRighton
DR   Wikidata; Q116049292
RX   PubMed=6459055;
RX   PubMed=7067035;
CC   Population: Caucasian; British.
CC   Doubling time: 40.7 hours (PubMed=6459055).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
RX   PubMed=6459055; DOI=10.1111/j.1469-1809.1981.tb00320.x;
RA   Delhanty J.D.A., Parrington J.M., Casey G., Attwood J., West L.,
RA   Kirk D., Corney G.;
RT   "Growth, DNA repair, sister chromatid exchange and chromosome studies
RT   in fibroblasts from Huntington's disease patients.";
RL   Ann. Hum. Genet. 45:181-198(1981).
//
RX   PubMed=7067035; DOI=10.1093/carcin/3.1.33;
RA   Teo I.A., Arlett C.F.;
RT   "The response of a variety of human fibroblast cell strains to the
RT   lethal effects of alkylating agents.";
RL   Carcinogenesis 3:33-37(1982).
//